| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $28.5M | — | +152.9% |
| Cost of Revenue | $22.8M | — | +67.1% |
| Gross Profit | $5.7M | — | +343.1% |
| R&D Expense | $3.8M | — | +89.7% |
| SG&A Expense | $8.6M | — | +62.6% |
| Operating Income | -$6.7M | — | +30.9% |
| Income Tax | $0 | — | — |
| Net Income | -$5.0M | — | +46.2% |
| EPS (Basic) | -$0.04 | — | +50.0% |
| EPS (Diluted) | -$0.04 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.4M | -31.1% | +28.8% |
| Accounts Receivable | $35.3M | +48.5% | +239.2% |
| Inventory | $8.2M | +22.4% | +106.0% |
| Current Assets | $114.0M | -9.9% | +72.3% |
| Total Assets | $130.8M | -16.6% | +10.4% |
| Current Liabilities | $16.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$37.3M | — | -163.9% |
| Capital Expenditures | $980K | — | +7.3% |
| Investing Cash Flow | -$625K | — | +31.5% |
| Financing Cash Flow | $8.6M | — | +0.9% |
| Free Cash Flow | -$38.3M | — | -154.4% |
| +14.5% |
| Total Liabilities | $21.4M | -59.7% | -55.5% |
| Stockholders' Equity | $109.4M | +5.4% | +55.4% |